Hetriva 18 Transdermal Patch 1's contains 'Rivastigmine' that belongs to the class of 'Acetylcholinesterase Inhibitors'. Rivastigmine increases the cholinergic effects allowing the nerve cells to communicate. It restores the balance of neurotransmitters and improves mental function, such as memory and thinking.
Hetriva 9 Transdermal Patches 1's contains 'Rivastigmine', an acetylcholinesterase inhibitor. It treats dementia in Alzheimer's and Parkinson's diseases by increasing acetylcholine levels in the central nervous system and enhancing the neurotransmission process.
